Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback